EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Transcatheter versus surgical aortic valve replacement in patients younger than 65 years in the United States

Sundos Alabbadi, Michael E Bowdish, Aminah Sallam, Derrick Y Tam, Irsa Hasan, Abirami Kumaresan, Anas H Alzahrani, Alexander Iribarne, Natalia Egorova, Joanna Chikwe

The Journal of Thoracic and Cardiovascular Surgery · 2025-09 · 170 (3) · 698-706.e19

DOI: 10.1016/j.jtcvs.2024.12.025 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025-09. Verfasst von Sundos Alabbadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Aortic Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The study objective was to characterize the trends and outcomes of aortic valve replacement in patients aged less than 65 years with aortic stenosis between 2013 and 2021. METHODS: This retrospective analysis included 9557 patients who underwent biological aortic valve replacement in California, New York, and New Jersey from 2013 to 2021. Patients were stratified by approach: transcatheter aortic valve replacement versus surgical aortic valve replacement. Our primary outcomes were 30-day and 6-year mortality and morbidity (stroke, heart failure rehospitalization, reintervention, and new pacemaker implantation). After propensity score matching, Cox proportional hazard and Fine-Gray models were used to compare outcomes after transcatheter aortic valve replacement and surgical aortic valve replacement. RESULTS: The proportion of patients aged less than 65 years with aortic stenosis undergoing transcatheter aortic valve replacement versus surgical aortic valve replacement increased from 7.1% in 2013 to 54.7% in 2021. After propensity score matching, 30-day mortality was similar between both groups (1.0% vs 1.5%, P = .33). Transcatheter aortic valve replacement had a higher 6-year mortality (23.3% vs 10.5%, hazard ratio, 2.27; 95% CI, 1.82-2.83; P < .001). The 30-day rate of new pacemaker implantation was higher after transcatheter aortic valve replacement (10.7% vs 6.2%, P < .001). There was no difference in the 6-year cumulative incidence of stroke, heart failure hospitalizations, or reoperations. Multiple sensitivity analyses confirmed these findings. CONCLUSIONS: Despite clinical guidelines, the use of transcatheter aortic valve replacement has increased in patients aged less than 65 years. Transcatheter aortic valve replacement in this population is associated with a higher 6-year mortality and a higher rate of new permanent pacemaker implantation when compared with a matched cohort treated with biologic surgical aortic valve replacement. These findings support the need for a randomized controlled trial comparing long-term outcomes of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients aged less than 65 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisAortic ValveHeart Valve Prosthesis ImplantationHumansMaleFemaleRetrospective StudiesUnited StatesAge FactorsMiddle AgedTreatment OutcomeTime FactorsRisk FactorsPostoperative ComplicationsRisk AssessmentAgedHeart Valve Prosthesis

Stichwörter der Autor:innen

CoxFine and GrayRMETTAVRaortic valve replacementpropensity score matchingsHR

Autor:innen und Institutionen

  • Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif.
  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif; National Clinician Scholars Program, University of California, Los Angeles, Los Angeles, Calif.
  • Department of Cardiothoracic Surgery, Staten Island University Hospital, Northwell Health, New York, NY.
  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif. Electronic address: Joanna.Chikwe@cshs.org.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Alabbadi, S., Bowdish, M. E., Sallam, A., Tam, D. Y., Hasan, I., Kumaresan, A., Alzahrani, A. H., Iribarne, A., Egorova, N., & Chikwe, J. (2025). Transcatheter versus surgical aortic valve replacement in patients younger than 65 years in the United States. The Journal of Thoracic and Cardiovascular Surgery, 170(3), 698-706.e19. https://doi.org/10.1016/j.jtcvs.2024.12.025

Vancouver

Alabbadi S, Bowdish ME, Sallam A, Tam DY, Hasan I, Kumaresan A, et al. Transcatheter versus surgical aortic valve replacement in patients younger than 65 years in the United States. The Journal of Thoracic and Cardiovascular Surgery. 2025;170(3):698-706.e19. doi:10.1016/j.jtcvs.2024.12.025

BibTeX
@article{Alabbadi2025,
  author = {Alabbadi, Sundos and Bowdish, Michael E and Sallam, Aminah and Tam, Derrick Y and Hasan, Irsa and Kumaresan, Abirami and Alzahrani, Anas H and Iribarne, Alexander and Egorova, Natalia and Chikwe, Joanna},
  title = {Transcatheter versus surgical aortic valve replacement in patients younger than 65 years in the United States},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  volume = {170},
  number = {3},
  pages = {698--706.e19},
  doi = {10.1016/j.jtcvs.2024.12.025}
}
Kostenlos starten →